Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Artificial Intelligence
Biotech
After ‘tough years,’ Frontier is ramping up clinical ambitions
Frontier CEO Chris Varma, Ph.D., told Fierce the biotech's team “have come back from” a tough period and want to ramp up their clinical ambitions.
Will Maddox
Aug 27, 2026 9:50am
AI clinical trial agent delivers up to 82 times ROI in oncology
Aug 12, 2026 3:16pm
Novo and Amazon sign drug discovery pact, launch innovation hub
Aug 10, 2026 8:00am
Icon inks Anthropic deal to deploy Claude into clinical trials
Aug 4, 2026 4:20pm
GSK, AI biotech Relation pen $110M biological datasets pact
Jul 30, 2026 9:46am
NIH joins Trump’s $5B AI mission with biomedical research push
Jul 22, 2026 2:43pm
